Evidence-based treatment planning in mCRC- The key to maximising outcomes

Summary of Presentations from the Roche Sponsored Satellite Symposium, European Cancer Congress 2013, Amsterdam, the Netherlands

Chairperson: Dirk Arnold1
Speakers: Eric Van Cutsem,2 Sharlene Gill3

1. Medical Director of the Hubertus Wald Tumor Center at the University Cancer Center, Hamburg, Germany
2. Professor of Internal Medicine, Head of Digestive Oncology, University Hospital Gathuisberg, Leuven, Belgium
3. Associate Professor of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada

Disclosure: For speaker disclosures, see page 37.
Acknowledgements: Writing assistance provided by Lynda McEvoy, ApotheCom Scope Medical.
Citation: EMJ Oncol. 2013;1:32-37.


This Roche sponsored satellite symposium was held as part of the European Cancer Congress 2013, and reviewed the current evidence available on treatment options for metastatic colorectal cancer and the application of this evidence to clinical practice.

Download (PDF, 86KB)

Leave a Reply